Kura Oncology, Inc. (KURA) Social Stream
KURA ONCOLOGY INC (KURA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KURA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 5 | $53 | $41 | $47.25 | $13.32 | 254.73% |
| 2021-11-24 | 5 | $53 | $41 | $46.75 | $13.32 | 250.98% |
| 2021-12-14 | 5 | $50 | $32 | $40.75 | $13.32 | 205.93% |
| 2022-01-03 | 6 | $56 | $32 | $42.25 | $13.32 | 217.19% |
| 2022-02-25 | 6 | $56 | $32 | $40.8 | $13.32 | 206.31% |
| 2022-05-05 | 6 | $56 | $28 | $38.2 | $13.32 | 186.79% |
| 2022-07-12 | 7 | $56 | $28 | $36.833 | $13.32 | 176.52% |
| 2022-08-04 | 6 | $40 | $28 | $33.2 | $13.32 | 149.25% |
| 2022-11-03 | 7 | $40 | $28 | $33.2 | $13.32 | 149.25% |
| 2022-12-12 | 7 | $40 | $28 | $32.666 | $13.32 | 145.24% |
| 2023-01-24 | 7 | $40 | $28 | $32.5 | $13.32 | 143.99% |
| 2023-01-31 | 8 | $40 | $25 | $31.428 | $13.32 | 135.95% |
| 2023-02-09 | 7 | $40 | $25 | $31.857 | $13.32 | 139.17% |
| 2023-02-24 | 8 | $40 | $25 | $31.857 | $13.32 | 139.17% |
| 2023-04-19 | 9 | $40 | $22 | $30.625 | $13.32 | 129.92% |
| 2023-05-11 | 9 | $40 | $22 | $30.5 | $13.32 | 128.98% |
| 2023-05-17 | 10 | $40 | $22 | $30.555 | $13.32 | 129.39% |
The Trend in the Analyst Price Target
Over the past 36 months, KURA's average price target has gone up $6.18.
Over the past 44 weeks, KURA's average upside potential has been 136.47%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-04 | 7 | 40 | 28 | 32.666 | 15.08 | 116.62% |
| 2022-12-12 | 7 | 40 | 28 | 32.666 | 13.17 | 148.03% |
| 2023-01-24 | 7 | 40 | 28 | 32.500 | 14.09 | 130.66% |
| 2023-02-09 | 8 | 40 | 25 | 31.857 | 12.63 | 152.23% |
| 2023-05-11 | 9 | 40 | 22 | 30.500 | 12.40 | 145.97% |
KURA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 10 | 0 | 0 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 18 months, KURA's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, KURA ONCOLOGY INC's upside potential (average analyst target price relative to current price) is higher than 1568.07% of them.
- In the context of all US stocks, KURA ONCOLOGY INC's number of analysts covering the stock is higher than 681.82% of them.
- In terms of how KURA ONCOLOGY INC fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 1531.62% of that group.
- In terms of how KURA ONCOLOGY INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -507.98% of that group.
In the Pharmaceutical Products industry, IBIO, AMPE, and VTGN are the three stocks most similar to KURA ONCOLOGY INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding KURA using the data that counts. Try POWR Ratings for free.